Interleukin-4 and Prednisolone affect the matrix metalloproteinase-13 releasing from degenerative bovine nasal cartilage in vitro

1. Hunziker EB. Articular cartilage repair: are the intrinsic biological constraints undermining this process insuperable?. Osteoarthritis Cartilage. 1999; 7:15-28.10.1053/joca.1998.0159Open DOISearch in Google Scholar

2. Abramson SB, Yazici Y. Biologics in development for rheumatoid arthritis: Relevance to osteoarthritis. Adv Drug Deliv Rev. 2006; 58:212-25.10.1016/j.addr.2006.01.008Open DOISearch in Google Scholar

3. Hui W, Rowan A D, Cawston T. Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin1alpha. Ann Rheum Dis. 2001; 60:254-61.10.1136/ard.60.3.254Search in Google Scholar

4. Kevorkian L, Young DA, Darrah CS, Donell T, Shepstone L, Porter S, et al. Expression Profiling of Metalloproteinases and Their Inhibitors in Cartilage. Arthritis Rheum. 2004; 50:131-41.10.1002/art.11433Open DOISearch in Google Scholar

5. Kozaci LD, Buttle DJ, Hollander AP. Degradation of type II collagen, but not proteoglycan, correlated with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum. 1997; 40:164-74.10.1002/art.1780400121Open DOISearch in Google Scholar

6. Takaishi H, Kimura T, Dalal S, Okada Y, D’Armiento J. Joint diseases and matrix metalloproteinases: A role for MMP-13. Curr Pharm Biotechnol. 2008; 9:47-54.10.2174/138920108783497659Open DOISearch in Google Scholar

7. Shingleton WD, Ellis AJ, Rowan AD, Cawston TE. Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: Matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown. J Cell Biochem. 2000; 79:519-31. 10.1002/1097-4644(20001215)79:4<519::AID-JCB10>3.0.CO;2-UOpen DOISearch in Google Scholar

8. Kozaci LD, Oktay G, Hollander AP. Effects of interleukin 1(IL1)-induced matrix breakdown on chondrocyte morphology in bovine nasal cartilage explants. Turk J Vet Anim Sci. 2005; 29:951-7.Search in Google Scholar

9. Yeh LA, Augustine AJ, Lee P, Riviere LR, Sheldon A. Interleukin-4, an inhibitor of cartilage breakdown in bovine articular cartilage explants. J Rheumatol. 1995; 22:1740-6.Search in Google Scholar

10. Joosten LA, Lubberts E, Helsen MM, Saxne T, Coenen-de Roo CJ, Heinegard D, van den Berg WB. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen induced arthritis. Arthritis Res. 1999; 1:81-91.10.1186/ar14Open DOISearch in Google Scholar

11. Cleaver CS, Rowan AD, Cawston TE. Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines. Ann Rheum Dis. 2001; 60:150-7.10.1136/ard.60.2.150Search in Google Scholar

12. Lacraz S, Nicod L, Galve-de Rochemonteix BG. B, Baumberger C, Dayer JM. Suppression of metalloproteinase biosynthesis human alveolar macrophages by interleukin-4. J Clin Invest. 1992; 90: 382-8.10.1172/JCI115872Open DOISearch in Google Scholar

13. Chowdhury TT, Bader DL, Lee DA . Anti-inflammatory effects of IL-4 and dynamic compression in IL-1beta stimulated chondrocytes. Biochem Biophys Res Commun. 2006; 339:241-7.10.1016/j.bbrc.2005.11.016Search in Google Scholar

14. Augustine AJ, Oleksyszyn J. Glucocorticosteroids inhibit degradation in bovine cartilage explants stimulated with concomitant plasminogen and interleukin-1alpha. Inflamm Res. 1997; 46:60-4.10.1007/s000110050073Open DOISearch in Google Scholar

15. Ibanez M, Ortiz AM, Castrejon I, Garcia-Vadillo A, Carvajal I, Castaneda S, et al. A rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass.in patients with early arthritis has a minimal impact on bone mass. Arthritis Res Ther. 2010; 12:R50.10.1186/ar2961Open DOISearch in Google Scholar

16. Shohani B, Orazizadeh M, Hashemitabar M, Heinegard D. Degradation of extracellular matrix molecules in interleukin-1­treated bovine nasal cartilage. Iran Biomed J. 2010; 14:158-63.Search in Google Scholar

17. Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm. 2005; 288:369-76.10.1016/j.ijpharm.2004.09.018Search in Google Scholar

18. Karsdal M A, Madsen SH, Christiansen C, Henriksen K, Fosang A J, Sondergaard B C. Cartilage degradation is fully reversible in the presence of aggrecanase but not matrix metalloproteinase activity. Arthritis Res Ther. 2008;10:R63.10.1186/ar2434Open DOISearch in Google Scholar

19. Laemmli UK. Cleavage of structure proteins during the assembly of the head of bacteriophage-T4. Nature. 1970; 227:680-5.10.1038/227680a0Search in Google Scholar

20. Dickinson SC, Vankemmelbeke MN, Buttle DJ, Rosenberg K, Heinegard D, Hollander AP. Cleavage of cartilage oligomeric matrix protein (thrombospondin- 5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospond in motifs. Matrix Biol. 2003; 22:267-78.10.1016/S0945-053X(03)00034-9Open DOISearch in Google Scholar

21. Pattoli MA, MacMaster JF, Gregor KR, Burke JR. Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression. J Pharmacol Exp Ther. 2005; 315:382-8.10.1124/jpet.105.087569Search in Google Scholar

22. Nemoto O, Yamada H, Kikuchi T, Shinmei M, Obata K, Sato H, Seiki M. Suppression of matrix metalloproteinase-3 synthesis by interleukin-4 in human articular chondrocytes. J Rheumatol. 1997; 24: 1774-9.Search in Google Scholar

23. Van de Loo FA, Arntz OJ, Enckevort FH, van Lent PL, van den Berg WB. Reduced cartilage proteoglycan loss during zymosan induced gonarthritis in NOS-2 deficient mice and in anti-interleukin-1 treated wild type mice with unabated joint inflammation. Arthritis Rheum. 1998; 41:634-46.10.1002/1529-0131(199804)41:4<634::AID-ART10>3.0.CO;2-1Open DOISearch in Google Scholar

24. Shimizu A, Watanabe S, Iimoto S, Yamamoto H. Interleukin-4 protects matrix synthesis in chondrocytes under excessive mechanical stress in vitro. Modern Rheumatol. 2004; 14:296-300.10.3109/s10165-004-0312-7Open DOISearch in Google Scholar

25. Arsenis C, McDonnell J. Effects of antirheumatic drugs on the interleukin-1alpha induced synthesis and activation of proteinases in articular cartilage explants in culture. Agents Actions.1989; 27:261-4.10.1007/BF019727912678951Open DOISearch in Google Scholar

26. Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, Yamada T, et al. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage. 2005; 13: 632-41.10.1016/j.joca.2005.03.00415896985Open DOISearch in Google Scholar

27. Milner JM, Rowan AD, Cawston TE, Young DA. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis. Arthritis Res Ther. 2006; 8:R142.10.1186/ar2034177943116919164Search in Google Scholar

28. Barmina OA, Walling HW, Fiacco GJ, Frije JM, Lopez-Otin C, Jeffrey JJ, et al. Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J Biol Chem. 1999; 274:30087-93.10.1074/jbc.274.42.3008710514495Search in Google Scholar

29. Richardson DW, Dodge GR. Dose-dependent effects of corticosteroids on the expression of matrix related genes in normal and cytokine-treated articular chondrocytes. Inflamm Res. 2003; 52:39-49.10.1007/s00011030001212608648Open DOISearch in Google Scholar